Effects of mycophenolate mofetil combined with corticosteroids for induction therapy of microscopic polyangiitis - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1159/000324364. Epub 2011 Feb 11.
Affiliations
- PMID: 21311184
- DOI: 10.1159/000324364
Randomized Controlled Trial
Effects of mycophenolate mofetil combined with corticosteroids for induction therapy of microscopic polyangiitis
Fei Han et al. Am J Nephrol. 2011.
Abstract
Aims: We prospectively compared the effects of oral mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVC) combined with corticosteroids for induction therapy of microscopic polyangiitis (MPA) with renal involvement over a follow-up period of 6 months.
Methods: 41 MPA patients were randomly assigned to either the open-label MMF group or the IVC group. Patients in the MMF group (n = 19) received oral MMF 1.0 g/day (1.5 g/day for patients with a body weight >70 kg) and patients in the IVC group (n = 22) received IVC in monthly pulses of 1.0 g per pulse (0.8 g per pulse for patients with a body weight <50 kg). Both groups received intravenous methylprednisolone 360-500 mg/day for 3 days, followed by oral prednisone 0.6-0.8 mg/kg/day and gradual tapering.
Results: There was no significant difference of estimated glomerular filtration rate (eGFR) level between the IVC and MMF groups at baseline. At 6 months, the eGFR level increased significantly in both groups, but there was no significant difference between the two. Three patients in the IVC group and 1 in the MMF group received maintenance dialysis within 6 months (p = 0.36). The remission rate was 63.6% in the IVC group and 78.9% in the MMF group (p = 0.23).
Conclusion: MMF is effective for inducing remission in Chinese MPA patients and may represent an alternative therapy to monthly impulses of IVC.
Copyright © 2011 S. Karger AG, Basel.
Similar articles
- The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis.
Ren P, Han F, Chen L, Xu Y, Wang Y, Chen J. Ren P, et al. Am J Nephrol. 2012;36(3):271-7. doi: 10.1159/000341914. Epub 2012 Sep 7. Am J Nephrol. 2012. PMID: 22965140 - Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.
Silva F, Specks U, Kalra S, Hogan MC, Leung N, Sethi S, Fervenza FC. Silva F, et al. Clin J Am Soc Nephrol. 2010 Mar;5(3):445-53. doi: 10.2215/CJN.06010809. Epub 2010 Jan 21. Clin J Am Soc Nephrol. 2010. PMID: 20093349 Free PMC article. Clinical Trial. - Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z. Ong LM, et al. Nephrology (Carlton). 2005 Oct;10(5):504-10. doi: 10.1111/j.1440-1797.2005.00444.x. Nephrology (Carlton). 2005. PMID: 16221103 Clinical Trial. - Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
Dall'Era M. Dall'Era M. Curr Opin Rheumatol. 2011 Sep;23(5):454-8. doi: 10.1097/BOR.0b013e328349a1e5. Curr Opin Rheumatol. 2011. PMID: 21720247 Review. - Severe Enteritis after Cyclophosphamide Administration in a Patient with Microscopic Polyangiitis: A Case Report and Literature Review.
Yoshida S, Temmoku J, Asano T, Iwasaki T, Matsumoto H, Fujita Y, Yashiro-Furuya M, Matsuoka N, Gunji N, Sato S, Watanabe H, Ohira H, Migita K. Yoshida S, et al. Intern Med. 2023 May 1;62(9):1279-1285. doi: 10.2169/internalmedicine.0434-22. Epub 2022 Sep 13. Intern Med. 2023. PMID: 36104200 Free PMC article. Review.
Cited by
- Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations.
Casal Moura M, Gauckler P, Anders HJ, Bruchfeld A, Fernandez-Juarez GM, Floege J, Frangou E, Goumenos D, Segelmark M, Turkmen K, van Kooten C, Tesar V, Geetha D, Fervenza FC, Jayne DRW, Stevens KI, Kronbichler A. Casal Moura M, et al. Nephrol Dial Transplant. 2023 Oct 31;38(11):2637-2651. doi: 10.1093/ndt/gfad090. Nephrol Dial Transplant. 2023. PMID: 37164940 Free PMC article. - Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome.
Huang X, Chen L, Lan L, Ren P, Ni A, Ma Y, Wang Y, Zhu Y, Xu Y, Chen J, Han F. Huang X, et al. Front Immunol. 2021 Jul 9;12:641655. doi: 10.3389/fimmu.2021.641655. eCollection 2021. Front Immunol. 2021. PMID: 34305886 Free PMC article. - New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis.
Nozaki Y. Nozaki Y. Front Immunol. 2021 Apr 1;12:631055. doi: 10.3389/fimmu.2021.631055. eCollection 2021. Front Immunol. 2021. PMID: 33868250 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous